Shield Therapeutics plc
SHIEF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$27,182 | -$33,293 | -$40,444 | -$19,678 |
| Dep. & Amort. | $1,425 | $1,071 | $2,362 | $2,207 |
| Deferred Tax | $0 | $0 | $14,716 | $1,759 |
| Stock-Based Comp. | $860 | $686 | $754 | $992 |
| Change in WC | $14,580 | -$7,024 | $3,925 | -$2,007 |
| Other Non-Cash | $3,547 | $1,434 | -$1 | -$11 |
| Operating Cash Flow | -$6,770 | -$29,123 | -$18,247 | -$16,738 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$35 | -$187 | -$1,895 | -$2,064 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | -$2,120 | -$2,243 | $200 | $13 |
| Investing Cash Flow | -$2,155 | -$2,430 | -$1,695 | -$2,051 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $4,383 | $23,998 | $9,080 | -$76 |
| Stock Issued | $122 | $26,817 | $87 | $37,392 |
| Stock Repurch. | $0 | $0 | -$82 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$3,078 | -$1,159 | -$1,378 | -$9,732 |
| Financing Cash Flow | $1,427 | $49,656 | $7,707 | $27,584 |
| Forex Effect | $74 | $446 | $2,939 | $382 |
| Net Chg. in Cash | -$7,424 | $10,546 | -$9,296 | $9,177 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $13,948 | $3,402 | $12,117 | $2,940 |
| End Cash | $6,524 | $13,948 | $2,821 | $12,117 |
| Free Cash Flow | -$9,191 | -$40,074 | -$20,142 | -$18,802 |